Immunological detection and cytotoxic properties of toxins from toxin A-positive, toxin B-positive Clostridium difficile variants
- 1 March 2004
- journal article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 53 (3) , 197-205
- https://doi.org/10.1099/jmm.0.05404-0
Abstract
Clostridium difficile is a major nosocomial pathogen and a causative agent of antibiotic-associated diarrhoea and pseudomembranous colitis. PCR analysis of the toxin A and B genes of this bacterium has revealed 20 variant types (toxinotypes I–XX), many of which can cause human disease. Strains comprising the 15 toxin A-positive, toxin B-positive toxinotypes are not usually differentiated from non-variant strains by routine laboratories that do not utilize PCR tests. Consequently, the toxins from these variant strains have not been investigated thoroughly. The present studies revealed that toxin A-positive (A+B+) strains representing 12 variant toxinotypes all express considerably lower levels of toxin A and are less cytotoxic in vitro than non-variant strain VPI 10463. Truncated forms of toxin A were detected by immunoblotting in toxinotype VI and VII strains and these toxins were differentiated from each other and from toxin A of the non-variant strain. A further novel finding was the ability of toxin A-positive (A+B+) strains of toxinotypes IX, XIV and XV to exhibit an alternative Clostridium sordellii-like cytopathic effect on Vero cells, characterized by marked cell clumping. A rapid and simple method for toxin A removal from culture filtrates was developed. This enabled confirmation that the abnormal cytotoxicity observed for these strains is due to an altered toxin B, as has been found in toxin A-negative (A−B+) strains. These findings indicate the potential for differentiation of certain toxin A-positive (A+B+) toxinotypes without the need for PCR techniques.Keywords
This publication has 22 references indexed in Scilit:
- Prevalence and Genetic Characterization of Toxin A Variant Strains of Clostridium difficile among Adults and Children with Diarrhea in FranceJournal of Clinical Microbiology, 2002
- Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factorProceedings of the National Academy of Sciences, 2001
- Pseudomembranous Colitis Caused by a Toxin A − B + Strain of Clostridium difficileJournal of Clinical Microbiology, 2000
- A Novel Cytotoxin from Clostridium difficileSerogroup F Is a Functional Hybrid between Two Other Large Clostridial CytotoxinsJournal of Biological Chemistry, 1999
- Multicentre Evaluation of a Commercial Test for the Rapid Diagnosis of Clostridium difficile -Mediated Antibiotic-Associated DiarrhoeaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells.Journal of Clinical Investigation, 1997
- Transcription Analysis of the Genes tcdA‐E of the Pathogenicity Locus of Clostridium DifficileEuropean Journal of Biochemistry, 1997
- Glucosylation of Rho proteins by Clostridium difficile toxin BNature, 1995
- Serogroup F strains of Clostridium difficile produce toxin B but not toxin AJournal of Medical Microbiology, 1993
- Molecular screening ofClostridium difficiletoxins A and B genetic determinants and identification of mutant strainsFEMS Microbiology Letters, 1991